Jane Tirard

Azur Environmental provides analytical systems for monitoring water. The company was founded on December 18, 1984 and is headquartered in Carlsbad, CA.

GE Healthcare Ltd. provides transformational medical technologies and services which include icenter, AssetPlus, preventive maintenance, continuity, digital solutions and Unisys multi brand probe repair services. The firm offers magnetic resonance imaging, hemodynamic recording, EP recording, metabolic health and computed tomography. The company was founded on February 16, 1971 and is headquartered in Little Chalfont, the United Kingdom.

Bionow Ltd. operates as a membership organization for biomedical and life-sciences industry. It offers a range of specialist business support products and services such as procurement, insurance, recruitment, events and other specialist services such as business planning and consultancy. The company was founded in March 2000 and is headquartered in Manchester, the United Kingdom.

Altimmune UK Ltd. engages in the discovery and development of prophylactic and therapeutic vaccines against mutating viruses and cancer. It provides T-cell vaccines to protect patients against infectious diseases (most notably mutating viruses) and to treat cancers; and Flunisyn, a DepoVaccine to protect against influenza. The company was founded by Bertrand Georges in 2003 and is headquartered in London, the United Kingdom.

Arrayjet Ltd. develops and produces microarray printing technologies for researchers, drug development groups, and diagnostic companies. Its products include Sprint, Marathon and Super Marathon, Ultra Marathon I and II Microarrayers. The company was founded by Howard John Manning, Peter Ghazal and Douglas Roy in 2000 and is headquartered in Roslin, the United Kingdom.

Arquer Diagnostics Ltd. develops proprietary diagnostic immunoassays for the detection of prostate and bladder cancer using urine samples. Its develops non-invasive, urine-based ELISA and Point-of Care tests meet the increased demand for cost-effective healthcare technologies that not only enhance patient care but help to reduce overall healthcare costs by improving patient outcomes. The firm will commercialise ELISA and point-of-care urine tests for prostate and bladder cancer for use in the urology clinic, hospital lab and the GP’s surgery. The company was founded by David Nicholas Miller-Jones and William Dawson in 2007 and is headquartered in Sunderland, the United Kingdom.

Fios Genomics Ltd. provides genomic and bioinformatics data analysis services. It offers access to a combined resource of in-house bioinformaticians, statisticians and biologists working together to analyze, interpret genomic, transcriptomic and proteomic data. The company was founded by Peter Ghazal in 2008 and is headquartered in Edinburgh, the United Kingdom.

Glycoscoredx Ltd. develops a novel blood test that revolutionizes how prostate cancer is diagnosed. The company is based in Newcastle upon Tyne, UK. The British company was founded in 2020 by Jennifer Munkley. Allan Brown has been the CEO of the company since 2020.